GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » EV-to-EBITDA

Gerresheimer AG (XTER:GXI) EV-to-EBITDA : 10.94 (As of May. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Gerresheimer AG's enterprise value is €4,465 Mil. Gerresheimer AG's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was €408 Mil. Therefore, Gerresheimer AG's EV-to-EBITDA for today is 10.94.

The historical rank and industry rank for Gerresheimer AG's EV-to-EBITDA or its related term are showing as below:

XTER:GXI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.41   Med: 10.09   Max: 14.7
Current: 10.93

During the past 13 years, the highest EV-to-EBITDA of Gerresheimer AG was 14.70. The lowest was 7.41. And the median was 10.09.

XTER:GXI's EV-to-EBITDA is ranked better than
66.67% of 486 companies
in the Medical Devices & Instruments industry
Industry Median: 16.29 vs XTER:GXI: 10.93

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-15), Gerresheimer AG's stock price is €100.50. Gerresheimer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was €3.460. Therefore, Gerresheimer AG's PE Ratio for today is 29.05.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Gerresheimer AG EV-to-EBITDA Historical Data

The historical data trend for Gerresheimer AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG EV-to-EBITDA Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.73 13.37 12.14 9.78 9.73

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.64 12.19 13.14 9.73 11.66

Competitive Comparison of Gerresheimer AG's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's EV-to-EBITDA falls into.



Gerresheimer AG EV-to-EBITDA Calculation

Gerresheimer AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4464.894/408.297
=10.94

Gerresheimer AG's current Enterprise Value is €4,465 Mil.
Gerresheimer AG's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €408 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gerresheimer AG  (XTER:GXI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Gerresheimer AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=100.50/3.460
=29.05

Gerresheimer AG's share price for today is €100.50.
Gerresheimer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.460.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Gerresheimer AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines